Medtronic (MDT +0.3%) receives FDA and CE Mark approval for its Arctic Front Advance cardiac cryoballoon for the treatment of paroxysmal atrial fibrillation. MDT has the only cryoballoon system currently on the market worldwide, which is purported to provide a more efficient approach to treating the condition than through point-by-point, radiofrequency ablation.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Thu, 5:10PM)
at Zacks.com (Tue, 4:53PM)
UPDATE: Medtronic plc: FDA Approves the VenaSeal Closure System for Treatment of Clinically Symptomatic Venous Refluxat Benzinga.com (Tue, 1:02PM)
at Zacks.com (Mon, 3:36PM)
at Investor's Business Daily (Feb 19, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs